Seroprevalence of hepatitis B surface antigen in pregnant women attending antenatal clinic in Honiara Solomon Islands,2015

被引:2
作者
Aneley Getahun [1 ]
Margaret Baekalia [2 ]
Nixon Panda [3 ]
Alice Lee [4 ]
Elliot Puiahi [5 ]
Sabiha Khan [1 ]
Donald Tahani [5 ]
Doris Manongi [5 ]
机构
[1] Department of Public Health and Primary Care,College of Medicine Nursing and Health Sciences,Fiji National University
[2] Department of Health and Social Affairs,Yap State Hospital
[3] School of Nursing and Allied Health Sciences,Solomon Islands National University
[4] Concord Repatriation General Hospital,University of Sydney
[5] National Referral Hospital
关键词
Hepatitis B; Chronic hepatitis; Hepatitis B surface antigen; Hepatitis Be antigen; Seroprevalence; Pregnant women; Solomon Islands;
D O I
暂无
中图分类号
R714.251 [传染病];
学科分类号
100211 ;
摘要
AIM To determine the seroprevalence of hepatitis B surface antigen(HBsAg) among pregnant women attending antenatal clinic in Honiara, Solomon Islands. METHODS This descriptive cross-sectional study was carried out in seven area health centers in Honiara. From March to June 2015, identification of eligible pregnant women in each site was conducted using systematic random sampling technique. A total of 243 pregnant women who gave written informed consent were enrolled. Standardized tool was used to record demographics, obstetric history and serology results. HBsAg and hepatitis B e antigen(HBeAg) were tested using point-of-care rapid diagnostic test. All HBsAg positive samples were verified using enzyme-linked immunosorbent assay. RESULTS The mean age of participants was 26 ± 6 years. The overall hepatitis HBsAg prevalence was 13.8% with higher rate(22%) reported in women between 30-34 years of age. Majority of HBsAg positive participants were Melanesians(29 out for 33). None of the pregnant women in the 15-19 years and ≥ 40 years tested positive for HBsAg. There was no statistically significant difference in HBsAg prevalence by age, ethnicity, education and residential location. The overall HBeAg seroprevalence was 36.7%. Women between 20-24 years of age had the highest rate of 54.5%. Low level of knowledge about hepatitis B vaccination was reputed. Overall, 54.6% of participants were not aware of their hepatitis B vaccination status and only 65.2% of mothers reported their child had been vaccinated. CONCLUSION Hepatitis B is a disease of public health importance in Solomon Islands and emphasize the need for integrated preventative interventions for its control.
引用
收藏
页码:1521 / 1528
页数:8
相关论文
共 9 条
[1]   Genotypes and viral variants in chronic hepatitis B: A review of epidemiology and clinical relevance [J].
Catherine MN Croagh ;
Paul V Desmond ;
Sally J Bell .
World Journal of Hepatology, 2015, (03) :289-303
[2]   Hepatitis B:Epidemiology and prevention in developing countries [J].
Elisabetta Franco ;
Barbara Bagnato ;
Maria Giulia Marino ;
Cristina Meleleo ;
Laura Serino ;
Laura Zaratti .
World Journal of Hepatology, 2012, (03) :74-80
[3]  
K.W. Cheung,M.T.Y. Seto,S.F. Wong.Towards complete eradication of hepatitis B infection from perinatal transmission: review of the mechanisms of in utero infection and the use of antiviral treatment during pregnancy[J].European Journal of Obstetrics and Gynecology,2013(1)
[4]  
H.Scheiblauer,M.El‐Nageh,S.Diaz,S.Nick,H.Zeichhardt,H.‐P.Grunert,A.Prince.Performance evaluation of 70 hepatitis B virus (HBV) surface antigen (HBsAg) assays from around the world by a geographically diverse panel with an array of HBV genotypes and HBsAg subtypes[J].Vox Sanguinis,2010(3p2)
[5]   Molecular epidemiological study of hepatitis B virus infection in two different ethnic populations from the Solomon Islands [J].
Utsumi, Takako ;
Yano, Yoshihiko ;
Truong, Bui Xuan ;
Tanaka, Yasuhito ;
Mizokami, Masashi ;
Seo, Yasushi ;
Kasuga, Masato ;
Kawabata, Masato ;
Hayashi, Yoshitake .
JOURNAL OF MEDICAL VIROLOGY, 2007, 79 (03) :229-235
[6]  
Ka Yu Tse,Lai Fong Ho,Terence Lao.The impact of maternal HBsAg carrier status on pregnancy outcomes: A case–control study[J].Journal of Hepatology,2005(5)
[7]   The effectiveness of the infant hepatitis B immunisation program in Fiji, Kiribati, Tonga and Vanuatu [J].
Wilson, N ;
Ruff, TA ;
Rana, BJ ;
Leydon, J ;
Locarnini, S .
VACCINE, 2000, 18 (26) :3059-3066
[8]   HEPATITIS-B VACCINATION OF BABIES IN MELANESIA [J].
MILNE, A ;
RODGERS, E ;
HOPKIRK, N .
LANCET, 1995, 346 (8970) :318-318
[9]   RAPID RESOLUTION OF PULMONARY-EMBOLISM BY TISSUE PLASMINOGEN-ACTIVATOR [J].
INTENZO, CM ;
PARK, CH ;
KIM, SM .
CLINICAL NUCLEAR MEDICINE, 1989, 14 (11) :801-802